Trial Profile
A study to evaluate whether the efficacy of nab-paclitaxel is associated with secreted protein acidic and rich in cysteine (SPARC) in patients with metastatic breast cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics
- 10 Dec 2015 New trial record